Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment, and Early-Stage Alzheimer's Disease

Cited by (511)

Items 201–300 of 511

1. The PREVENT research programme – A novel research programme to identify and manage midlife risk for dementia: the conceptual framework
   Craig William Ritchie, Katie Wells, Karen A. Ritchie · 2013 · International Review of Psychiatry
2. Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals
   Pavel Katsel, Weilun Tan, Vahram H. Haroutunian · 2009 · PLoS ONE
3. Mild cognitive impairment (MCI) twenty years on
   Karen A. Ritchie, Craig William Ritchie · 2011 · International Psychogeriatrics
4. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease
   Xia Li, Tie‐Qiang Li, Nancy C. Andreasen, Maria Kristoffersen Wiberg, Eric Westman, Lars‐Olof Wahlund · 2013 · Journal of Internal Medicine
5. Selective memory and behavioral alterations after ambient ultrafine particulate matter exposure in aged 3xTgAD Alzheimer’s disease mice
   Katrina Jew, Denise Herr, Candace Wong, Andrea J Kennell, Keith Morris‐Schaffer, Günter Oberdörster, M. Kerry O’Banion, Deborah A. Cory‐Slechta, Alison C. P. Elder · 2019 · Particle and Fibre Toxicology
6. Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study
   Xiong, Chengjie, Jasielec, Mateusz S., Weng, Hua, Fagan, Anne M., Benzinger, Tammie L.S., Head, Denise, Hassenstab, Jason, Grant, Elizabeth, Sutphen, Courtney L., Buckles, Virginia et al. · 2016 · Neurology
7. Cognitive load associates prolonged P300 latency during target stimulus processing in individuals with mild cognitive impairment
   Pınar Demirayak, İlayda Kıyı, Yağmur Özbek, Görsev Yener · 2023 · Scientific Reports
8. Cognitive recovery by chronic activation of the large-conductance calcium-activated potassium channel in a mouse model of Alzheimer's disease
   Li Wang, Huicong Kang, Yongzhi Li, Yuan Shui, Ryo Yamamoto, Tokio Sugai, Nobuo Kato · 2015 · Neuropharmacology
9. Argyrophilic Grain Disease in Demented Subjects Presenting Initially With Amnestic Mild Cognitive Impairment
   Gregory A. Jicha, Ronald Carl Petersen, David S. Knopman, Bradley F. Boeve, Glenn E. Smith, Yonas E. Geda, Kris Johnson, Ruth H. Cha, Michael W. DeLucia, Heiko Braak et al. · 2006 · Journal of Neuropathology & Experimental Neurology
10. Cerebrospinal Fluid β‐Amyloid and Tau Are Not Associated with Risk of Delirium: A Prospective Cohort Study in Older Adults with Hip Fracture
    Joost Witlox, Kees J. Kalisvaart, Jos F. M. de Jonghe, Nicolaas A. Verwey, Mireille F. M. van Stijn, Alexander P. J. Houdijk, Han S. Traast, Alasdair M. J. MacLullich, Willem A. van Gool, Piet Eikelenboom · 2011 · Journal of the American Geriatrics Society
11. New Research Criteria for the Diagnosis of Alzheimer’s Disease Applied in a Memory Clinic Population
    Femke H. Bouwman, Nicolaas A. Verwey, Martin Klein, Astrid Kok, Marinus A. Blankenstein, Jasper D. Sluimer, Frederik Barkhof, Wiesje M. van der Flier, Philip Scheltens · 2010 · Dementia and Geriatric Cognitive Disorders
12. Fingerprinting Alzheimer’s Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid
    Alessia Vignoli, Silvia Paciotti, Leonardo Tenori, Paolo Eusebi, Leonardo Biscetti, Davide Chiasserini, Philip Scheltens, Paola Turano, Charlotte Elisabeth Teunissen, Claudio Luchinat et al. · 2020 · Journal of Proteome Research
13. In vivo target bio-imaging of Alzheimer's disease by fluorescent zinc oxide nanoclusters
    Lanmei Lai, Chunqiu Zhao, Meina Su, Xiaoqi Li, Xiaoli Liu, Hui Jiang, Christian Andre Amatore, Xuemei Wang · 2016 · Biomaterials Science
14. Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
    T. Cassano, Silvio Calcagnini, A. Carbone, V. N. Bukke, S. Orkisz, Rosanna Villani, A. Romano, C. Avolio, S. Gaetani · 2019 · Frontiers in Pharmacology
15. Biological markers for early detection and pharmacological treatment of Alzheimer's disease
    Harald Juergen Hampel, Karl Broich, Yvonne C. Hoessler, Johannes Pantel · 2009 · Dialogues in Clinical Neuroscience
16. Validation and optimization of statistical approaches for modeling odorant-induced fMRI signal changes in olfactory-related brain areas
    Matthias H. Tabert, Jason Steffener, Mark W. Albers, David W. Kern, Maria Michael, Haiying Tang, Truman R. Brown, Davangere P. Devanand · 2006 · NeuroImage
17. Proteomic determination of widespread detergent insolubility, including Aβ but not tau, early in the pathogenesis of Alzheimer's disease
    Randall L. Woltjer, Patrick Joseph Cimino, Angela M. Boutté, Aimee M. Schantz, Kathleen S. Montine, Eric Berg Larson, Thomas D. Bird, Joseph F. Quinn, Jing Zhang, Thomas Jude Montine · 2005 · The FASEB Journal
18. Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
    Suzanne E. Schindler, Courtney L. Sutphen, Charlotte Elisabeth Teunissen, Lena M. McCue, John C. Morris, David M. Holtzman, Sandra D. Mulder, Philip Scheltens, Chengjie Xiong, Anne M. Fagan · 2017 · Alzheimer s & Dementia
19. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease
    Leah H. Rubin, Erin E. Sundermann, David J. Moore · 2019 · Journal of NeuroVirology
20. Strategies for the use of Ginkgo biloba extract, EGb 761 ® , in the treatment and management of mild cognitive impairment in Asia: Expert consensus
    Nagaendran Kandiah, Yee Fai Chan, Christopher Chen, Darwin Dasig, Jacqueline C. Dominguez, Seol‐Heui Han, Jianping Jia, SangYun Kim, Panita Limpawattana, Li‐Ling Ng et al. · 2020 · CNS Neuroscience & Therapeutics
21. Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria
    Linda L. Chao, Susanne G. Mueller, Shannon T. Buckley, Kevin Niall Peek, S. Raptentsetseng, Jeffrey L. Elman, Kristine S. Yaffe, Bruce L. Miller, Joel H. Kramer, Catherine A. Madison et al. · 2008 · Neurobiology of Aging
22. Neuroimaging biomarkers in Alzheimer’s disease and other dementias
    Victor L. Villemagne, Gaël Chételat · 2016 · Ageing Research Reviews
23. Advances in Brain Amyloid Imaging
    Natasha Krishnadas, Victor L. Villemagne, Vincent Doré, Christopher Cleon Rowe · 2021 · Seminars in Nuclear Medicine
24. Effects of age on the glucose metabolic changes in mild cognitive impairment
    Kantarci, K., Senjem, M.L., Lowe, V.J., Wiste, H.J., Weigand, S.D., Kemp, B.J., Frank, A.R., Shiung, M.M., Boeve, B.F., Knopman, D.S. et al. · 2010 · American Journal of Neuroradiology
25. Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer’s disease biomarkers
    Brian Andrew Gordon, Jeffrey M. Zacks, Tyler Blazey, Tammie L.S. Benzinger, John C. Morris, Anne M. Fagan, David M. Holtzman, David A. Balota · 2015 · Neurobiology of Aging
26. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model
    Levi M. Smith, Rong Zhu, Stephen M. Strittmatter · 2017 · Neuropharmacology
27. Canine cognitive deficit correlates with diffuse plaque maturation and S100β (−) astrocytosis but not with insulin cerebrospinal fluid level
    Marco Pugliese, Maria Concetta Geloso, Josep L. Carrasco, Joan Mascort, Fabrizio Michetti, Nicole Mahy · 2006 · Acta Neuropathologica
28. Prediction of Preclinical Alzheimer's Disease: Longitudinal Rates of Change in Cognition
    Kathryn Perez Riley, Gregory A. Jicha, Daron G. Davis, Erin L. Abner, Gregory E. Cooper, Nancy J. Stiles, Charles D. Smith, Richard J. Kryscio, Peter T. Nelson, Linda J. Van Eldik et al. · 2011 · Journal of Alzheimer s Disease
29. Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®)
    Carlo Tomino, Sara Ilari, Vincenzo Solfrizzi, Valentina Malafoglia, Guglielmo Zilio, Patrizia Russo, Stefania Proietti, Federica Marcolongo, Giovanni Scapagnini, Carolina Muscoli et al. · 2021 · Pharmaceuticals
30. Evaluation of Cholinergic Deficiency in Preclinical Alzheimer’s Disease Using Pupillometry
    Shaun M. Frost, Liam Robinson, Christopher Cleon Rowe, David J. Ames, Colin Louis Masters, Kevin Taddei, Stephanie Ruth Rainey‐Smith, Ralph Nigel Martins, Yogesan Kanagasingam · 2017 · Journal of Ophthalmology
31. Antecedent Biomarkers of Alzheimer’s Disease: The Adult Children Study
    Coats, Mary, Morris, John C. · 2005 · Journal of Geriatric Psychiatry and Neurology
32. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan
    Jingqin Rosy Luo, Folasade Agboola, Elizabeth Grant, John C. Morris, Colin Louis Masters, Marilyn Albert, Sterling C. Johnson, Eric McDade, Anne M. Fagan, Tammie L.S. Benzinger et al. · 2022 · Brain
33. Dementia and the Default Mode
    Lori L. Beason‐Held · 2011 · Current Alzheimer Research
34. Diagnostic biomarkers in Alzheimer’s disease
    Andersen, Emerlee, Casteigne, Bryce, Chapman, William Daniel, Creed, Andrew, Foster, Forrest, Lapins, Allison, Shatz, Rhonna, Sawyer, Russell P. · 2021 · Biomarkers in Neuropsychiatry
35. Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention
    Rawan M. Tarawneh, David M. Holtzman · 2009 · CNS & Neurological Disorders - Drug Targets
36. The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model
    Patricia R. Spilman, Olivier Descamps, Olivia F. Gorostiza, Clare A. Peters-Libeu, Karen S. Poksay, Alex Matalis, Jesus J. Campagna, Alexander Patent, Rammohan V. Rao, Varghese John et al. · 2014 · Brain Research
37. Mechanisms of memory loss in Aβ and tau mouse models
    Ashe, K.H. · 2005 · Biochemical Society Transactions
38. Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD
    Xiaozhen Li, Tie‐Qiang Li, Niels Andreasen, Maria Kristoffersen Wiberg, Eric Westman, Lars‐Olof Wahlund · 2013 · Scientific Reports
39. Dysregulation and Diagnostic Potential of microRNA in Alzheimer’s Disease
    Yaoqian Pan, Ruizhu Liu, Erin J.M. Terpstra, Yanqing Wang, Fangfang Qiao, Jin Wang, Yigang Tong, Bo Pan · 2015 · Journal of Alzheimer s Disease
40. Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age
    Olga Pletniková, Gay L. Rudow, Thomas M. Hyde, Joel E. Kleinman, Sabeen Z. Ali, Rahul A. Bharadwaj, Salina Gangadeen, Barbara J. Crain, David R. Fowler, Ana I. Rubio et al. · 2015 · Cognitive and Behavioral Neurology
41. Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings
    Pierre Payoux, Julien Delrieu, Adeline Gallini, Djilali Adel, Anne‐Sophie Salabert, Anne Hitzel, Christelle Cantet, Mathieu Tafani, Delphine de Verbizier, Jacques Darcourt et al. · 2015 · European Journal of Nuclear Medicine and Molecular Imaging
42. Biomarkers Predicting Alzheimer's Disease in Cognitively Normal Aging
    Yong Soo Shim, John C. Morris · 2011 · Journal of Clinical Neurology
43. Complement C1q expression induced by Aβ in rat hippocampal organotypic slice cultures
    Rong Fan, Andrea J. Tenner · 2003 · Experimental Neurology
44. Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD
    Suzanne E. Schindler, Anne M. Fagan · 2015 · Frontiers in Neurology
45. Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function
    Yi Su, Tyler Blazey, Abraham Z. Snyder, Marcus E. Raichle, Russ C. Hornbeck, Patricia Aldea, John C. Morris, Tammie L.S. Benzinger · 2015 · PLoS ONE
46. Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals
    Ira Frahmand Driscoll, Yun Zhou, Yang An, Jitka Sojkova, Christos A. Davatzikos, Michael A. Kraut, Weiguo Ye, Luigi Ferrucci, Chester A. Mathis, William Edward Klunk et al. · 2010 · Neurobiology of Aging
47. Laparoscopic versus open inguinal hernia repair in octogenarians: A follow‐up study
    Kai B. Dallas, Dvir Froylich, Jacqueline J. Choi, Jonatan Hernandez Rosa, Christopher Lo, Modesto J. Colón, Dana Alexa Telem, Celia Maria Divino · 2012 · Geriatrics and gerontology international/Geriatrics & gerontology international
48. Evolving brain structural changes in PSEN1 mutation carriers
    Roser Sala‐Llonch, Albert Lladó, Juan Fortea, Beatríz Bosch, Anna Antonell, Mircea Balasa, Núria Bargalló, David Bartrés-faz A, José Luís Molinuevo, Raquel Sánchez‐Valle · 2014 · Neurobiology of Aging
49. Leukocyte Telomere Length in Alzheimer’s Disease Patients with a Different Rate of Progression
    Enzo Tedone, Beatrice Arosio, Federico Colombo, Evelyn Ferri, Delphine Asselineau, F. Piette, Cristina Gussago, Joël Belmin, Sylvie Pariel, Khadija Benlhassan et al. · 2015 · Journal of Alzheimer s Disease
50. Braak stage and trajectory of cognitive decline in noncognitively impaired elders
    Elliott Jay Mufson, Michael H. Malek‐Ahmadi, Noelle L. Snyder, Jake Ausdemore, Kewei Chen, Sylvia E. Perez · 2016 · Neurobiology of Aging
51. So what if tangles precede plaques?
    Joseph L. Price, John C. Morris · 2004 · Neurobiology of Aging
52. Alpha7 neuronal nicotinic receptors: The missing link to understanding Alzheimer’s etiopathology?
    Merouane Bencherif, Patrick M. Lippiello · 2009 · Medical Hypotheses
53. Proton Magnetic Resonance Spectroscopic Evidence of Glial Effects of Cumulative Lead Exposure in the Adult Human Hippocampus
    Marc G. Weisskopf, Howard Hu, David Sparrow, Robert E. Lenkinski, Robert O. Wright · 2007 · Environmental Health Perspectives
54. Dementia Update 2003
    John C. Morris · 2003 · Alzheimer Disease & Associated Disorders
55. Maximizing the Potential of Plasma Amyloid-Beta as a Diagnostic Biomarker for Alzheimer’s Disease
    Esther S. Oh, Juan Carlos Troncoso, Stina M. Fangmark Tucker · 2008 · NeuroMolecular Medicine
56. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults
    Donata Paternicò, Samantha Galluzzi, Valeria Drago, Luisella Bocchio‐Chiavetto, Roberta Zanardini, Laura Pedrini, Manuela Baronio, Giovanni Amicucci, Giovanni Battista Frisoni · 2012 · Alzheimer s & Dementia
57. Challenging assumptions about Alzheimer's disease: Mild cognitive impairment and the cholinergic hypothesis
    John C. Morris · 2002 · Annals of Neurology
58. Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease
    Zhiping Mi, Eric E. Abrahamson, Angela Y. Ryu, Kenneth N. Fish, Robert A. Sweet, Elliott Jay Mufson, Miloš D. Ikonomović · 2017 · Neurobiology of Aging
59. Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease
    Marie M. Svedberg, Obaidur Rahman, Håkan Hall · 2012 · Nuclear Medicine and Biology
60. The mismatch negativity as an index of cognitive decline for the early detection of Alzheimer’s disease
    Manuela Ruzzoli, Cornelia Pirulli, Veronica Mazza, Carlo Miniussi, Debora Brignani · 2016 · Scientific Reports
61. Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men
    Gary Tong, Lorna Castaneda, Jun-Sheng Wang, Oleksandr Sverdlov, Shu‐Pang Huang, Randy Slemmon, Huidong Gu, Oi T. Wong, Hewei Li, Robert Berman et al. · 2012 · Clinical Drug Investigation
62. Amyloid Imaging in Alzheimer’s Disease and Other Dementias
    Michelle T. Fodero‐Tavoletti, Roberto Cappai, Catriona McLean, Kerryn Elizabeth Pike, Paul Anthony Adlard, Tiffany Cowie, Andrea R. Connor, Colin Louis Masters, Christopher Cleon Rowe, Victor L. Villemagne · 2009 · Brain Imaging and Behavior
63. Alzheimer?s disease?a sum greater than its parts?
    Paul Anthony Adlard, Brian J Cummings · 2004 · Neurobiology of Aging
64. Chronic traumatic encephalopathy – neuropathology in athletes and war veterans
    Nelli S. Lakis, Robert John Corona, Gentian Toshkezi, Lawrence S. Chin · 2013 · Neurological Research
65. Multimodal MRI ‐based imputation of the A β + in early mild cognitive impairment
    Duygu Tosun, Sarang C. Joshi, Michael Walter Weiner, Alzheimer’s Disease Neuroimaging Initiative · 2014 · Annals of Clinical and Translational Neurology
66. Effect of pathogenic mutations on the structure and dynamics of Alzheimer’s Aβ42-amyloid oligomers
    Kristin Kassler, Anselm H. C. Horn, Heinrich Sticht · 2009 · Journal of Molecular Modeling
67. Bivariate Heritability of Total and Regional Brain Volumes
    Anita L. DeStefano, Sudha S. Seshadri, Alexa Beiser, Larry D. Atwood, Joe M. Massaro, Rhoda Au, Philip A. Wolf, Charles S DeCarli · 2009 · Alzheimer Disease & Associated Disorders
68. Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine
    Md. Tanvir Kabir, Md. Sahab Uddin, Bijo Mathew, Pankoj Kumar Das, Asma Perveen, Ghulam Md Ashraf · 2020 · Current Topics in Medicinal Chemistry
69. Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models
    Daniel Zarhin, Refaela Atsmon, Antonella Ruggiero, Halit Baeloha, Shiri Shoob, Oded Scharf, Leore R. Heim, Nadav Buchbinder, Ortal Shinikamin, Ilana Shapira et al. · 2022 · Cell Reports
70. Amyloid imaging
    Victor L. Villemagne, Christopher Cleon Rowe · 2011 · International Psychogeriatrics
71. MRS in Mild Cognitive Impairment: Early Differentiation of Dementia with Lewy Bodies and Alzheimer's Disease
    Bing Zhang, Tanis J. Ferman, Bradley F. Boeve, Glenn E. Smith, Mandie Maroney‐Smith, Anthony J. Spychalla, David S. Knopman, Clifford R. Jack, Ronald Carl Petersen, Kejal Kantarci · 2014 · Journal of Neuroimaging
72. Neuropsychology and neuroimaging profiles of amyloid‐positive versus amyloid‐negative amnestic mild cognitive impairment patients
    Clémence Tomadesso, Vincent de La Sayette, Robin de Florès, Pierrick Bourgeat, Victor L. Villemagne, Stéphanie Egret, Francis Eustache, Gaël Chételat · 2018 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
73. Amyloid β and Alzheimer disease therapeutics: the devil may be in the details
    John R. Cirrito, David M. Holtzman · 2003 · Journal of Clinical Investigation
74. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets
    Carles Falcón, Alan Tucholka, Gemma C. Monté, Raffaele Cacciaglia, Grégory Operto, Lorena Rami, Juan Domingo Gispert, José Luís Molinuevo · 2018 · NeuroImage Clinical
75. Why Alzheimer's Disease Starts with a Memory Impairment: Neurophysiological Insight
    Yuri I. Arshavsky · 2010 · Journal of Alzheimer s Disease
76. A potential role for zinc alterations in the pathogenesis of Alzheimer's disease
    Ganna Lyubartseva A, Mark A. Lovell · 2012 · BioFactors
77. The War (on Terror) on Alzheimer’s
    Daniel R. George, Peter John Whitehouse · 2012 · Dementia
78. Amyloid PET Ligands for Dementia
    Victor L. Villemagne, Christopher Cleon Rowe · 2010 · PET Clinics
79. Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer’s patients
    Judith A. Potashkin, Virginie Bottero, José A. Santiago, James P. Quinn · 2019 · PLoS ONE
80. Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease
    Anna H. Boerwinkle, Julie K. Wisch, Charles D. Chen, Brian Andrew Gordon, Omar Hameed Butt, Suzanne E. Schindler, Courtney L. Sutphen, Shaney E. Flores, Aylin Dincer, Tammie L.S. Benzinger et al. · 2021 · Neurology
81. Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment
    David Allan Butterfield · 2023 · Antioxidants
82. Sensory Gating in Patients With Alzheimer’s Disease and Their Biological Children
    Brandon A. Ally, Gary E. Jones, Jack A. Cole, Andrew E. Budson · 2007 · American Journal of Alzheimer s Disease & Other Dementias®
83. Correlation of auditory event-related potentials and magnetic resonance spectroscopy measures in mild cognitive impairment
    Xiaoyi Li, Xicang Shao, Nanzhu Wang, Tao Wang, Geyu Chen, Huadong Zhou · 2010 · Brain Research
84. The search for antecedent biomarkers of Alzheimer's disease
    Anne M. Fagan, Cynthia A. Csernansky, John C. Morris, David M. Holtzman · 2006 · Journal of Alzheimer s Disease
85. Validation study of the Alzheimer’s disease assessment scale–cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer’s disease
    Joana Nogueira, Sandra Freitas, Diana Duro, Jorge Almeida, Isabel J. Santana · 2018 · The Clinical Neuropsychologist
86. Marriage work in older couples: Disclosure of marital problems to spouses and friends over time.
    Jakob F. Jensen, Amy Rauer · 2015 · Journal of Family Psychology
87. An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
    Rahul S. Desikan, Michael S. Rafii, James B. Brewer, Christopher Paul Hess · 2013 · American Journal of Neuroradiology
88. Disentangling Alzheimer’s disease neurodegeneration from typical brain ageing using machine learning
    Gyujoon Hwang, Ahmed Abdulkadir, Güray Erus, Mohamad Habes, Raymond Pomponio, Haochang Shou, Jimit J. Doshi, Elizabeth Mamourian, Tanweer Rashid, Murat Bilgel et al. · 2022 · Brain Communications
89. The Relationship between Associative Learning, Transfer Generalization, and Homocysteine Levels in Mild Cognitive Impairment
    Ahmed A. Moustafa, Doaa H. Hewedi, Abeer M. Eissa, Catherine E. Myers, Hisham A. Sadek · 2012 · PLoS ONE
90. Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
    Peng-hui Ai, Si Chen, Xian-Dong Liu, Xiao-Na Zhu, Yuan-Bo Pan, Dong-Fu Feng, Sheng-Di Chen, Nan-Jie Xu, Su-Ya Sun · 2020 · Translational Neurodegeneration
91. Factors associated with mild cognitive impairment among elderly patients attending medical clinics in Universiti Kebangsaan Malaysia Medical Centre
    Rosdinom Razali, Azlin Baharudin, Nik Ruzyanei Nik Jaafar, Hatta Sidi, Abdul‐Hadi Rosli, Khoo Boo Hooi, Lee Tyan Shin, Noor Hafizah Samsudin Bahari, Noralia Anis Elias · 2012 · Sains Malaysiana
92. Change in the mini-mental state exam in Alzheimer's disease over 2 years: The experience of a dementia clinic
    John Riley McCarten, Susan J. Rottunda, Michael A. Kuskowski · 2004 · Journal of Alzheimer s Disease
93. Age and apoE associations with complex pathologic features in Alzheimer's disease
    Gregory A. Jicha, Joseph E. Parisi, Dennis W. Dickson, Ruth H. Cha, Kris Johnson, Glenn E. Smith, Bradley F. Boeve, Ronald Carl Petersen, David S. Knopman · 2008 · Journal of the Neurological Sciences
94. The accuracy of 18 FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCI
    Marco Vacante, Nadja Smailagic, Christos Sachpekidis, Chris Hyde, Steven Martin, Obioha Chukwunyere Ukoumunne · 2013 · Cochrane Database of Systematic Reviews
95. CALHM1 P86L Polymorphism Modulates CSF Aβ Levels in Cognitively Healthy Individuals at Risk for Alzheimer’s Disease
    Jeremy L. Koppel, Fabien Campagne, Valérie Vingtdeux, Ute Dreses‐Werringloer, Michael Ewers, Dan Rujescu, Harald Juergen Hampel, Marc L. Gordon, Erica Christen, Julien Chapuis et al. · 2011 · Molecular Medicine
96. Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer’s Disease
    Julie K. Wisch, Catherine M. Roe, Ganesh Muneshwar Babulal, Suzanne E. Schindler, Anne M. Fagan, Tammie L.S. Benzinger, John C. Morris, Beau M. Ances · 2020 · Journal of Alzheimer s Disease
97. Role of biomarkers in studies of presymptomatic Alzheimer's disease
    John C. Morris, A. Kimberly, Kimberly A. Quaid, David M. Holtzman, Kejal Kantarci, Jeffrey Alan Kaye, Eric M. Reiman, William Edward Klunk, Eric Siemers · 2005 · Alzheimer s & Dementia
98. Identification of peptides that specifically bind Aβ1–40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display
    Christine Kang · 2003 · Neurobiology of Disease
99. Perseverations in Alzheimer's disease: Memory slips?
    Michele Miozzo, Simon Fischer‐Baum, Elise Caccappolo-van Vliet · 2012 · Cortex
100. Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke
     Michael S. Rafii, Matthew A. Koenig, Wendy Ziai · 2005 · Neurology